Search results
Showing 2701 to 2715 of 7688 results
Evidence standards framework for digital health technologies (ECD7)
This document describes an evidence standards framework (ESF) for digital health technologies (DHTs). It was developed by NICE between June 2018 and February 2019 in collaboration with NHS England, Public Health England and MedCity. The work was commissioned by NHS England.
Show all sections
- Overview
- Introduction
- Section A: Technologies suitable for evaluation using the evidence standards framework
- Section B: Classification of digital health technologies
- Section C: Evidence standards tables
- Terms used in the evidence standards framework
- How to meet the standards
- Section D: Early deployment standards for evidence-generation programmes
Accessing NHS care and treatment recommended by NICE
Interventional procedures programme manual
Good practice guidance – Interim process statement
Evidence summaries: process guide
User guide for the cost comparison company evidence submission template (PMG32)
User guide for the cost comparison company evidence submission template
Medical technologies evaluation programme methods guide (PMG33)
Medical technologies evaluation programme methods guide
Show all sections
- 1 Introduction
- 2 The medical technologies evaluation programme
- 3 Selecting and routing technologies
- 4 Principles for developing medical technologies guidance
- 5 Scope
- 6 Evidence and expert advice
- 7 Evidence synthesis and cost-consequence analysis
- 8 Evaluation of the evidence and decision-making by the committee
Medical technologies evaluation programme process guide (PMG34)
Medical technologies evaluation programme process guide
Show all sections
- 1 Introduction
- 2 The medical technologies evaluation programme
- 3 Who is involved in the medical technologies evaluation programme
- 4 Identifying, selecting and routing technologies for evaluation
- 5 How medical technologies guidance is developed
- 6 Resolution
- 7 Publishing medical technologies guidance
- 8 Reviews
Single technology appraisal and highly specialised technologies evaluation: User guide for company evidence submission template
Evidence summaries: new medicines – Integrated process statement (PMG11)
Evidence summaries: new medicines – Integrated process statement
Good practice guidance – Integrated process statement (PMG12)
Good practice guidance – Integrated process statement
Guide to the technology appraisal and highly specialised technologies appeal process (pre June 2023)
Interim clinical guideline surveillance process and methods guide 2013 (PMG16)
Interim clinical guideline surveillance process and methods guide 2013
Show all sections
Interim process and methods guide for the clinical guideline updates using standing committees pilot programme 2013
Evidence summaries: unlicensed and off-label medicines – Integrated process statement (PMG14)
Evidence summaries: unlicensed and off-label medicines – Integrated process statement